Lethal chondrodysplasia Moerman type

From WikiMD's Food, Medicine & Wellness Encyclopedia

Lethal Chondrodysplasia, Moerman Type is a rare genetic disorder characterized by severe skeletal abnormalities. This condition falls under the broader category of chondrodysplasia, which refers to disorders affecting the development of cartilage and bone. Lethal Chondrodysplasia, Moerman Type, is distinguished by its severity and the specific constellation of symptoms it presents.

Symptoms and Characteristics[edit | edit source]

The hallmark features of Lethal Chondrodysplasia, Moerman Type, include severely stunted growth of long bones, abnormal development of the rib cage, and distinctive facial features. Affected individuals may also exhibit:

  • Shortened limbs
  • Underdeveloped lungs due to a narrow thoracic cage
  • Polydactyly (extra fingers or toes)
  • Cleft palate or other craniofacial abnormalities

These symptoms are typically evident at birth, indicating the prenatal onset of the disorder.

Causes[edit | edit source]

Lethal Chondrodysplasia, Moerman Type, is caused by genetic mutations. The specific genes involved may vary among individuals, but these mutations disrupt the normal development of bone and cartilage. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.

Diagnosis[edit | edit source]

Diagnosis of Lethal Chondrodysplasia, Moerman Type, is primarily based on clinical evaluation and the characteristic physical findings. Prenatal imaging, such as ultrasound, may reveal signs of the disorder before birth. Genetic testing can confirm the diagnosis by identifying the causative mutations.

Treatment and Management[edit | edit source]

There is no cure for Lethal Chondrodysplasia, Moerman Type. Treatment focuses on managing symptoms and improving the quality of life for affected individuals. This may include:

  • Respiratory support for underdeveloped lungs
  • Surgical interventions to address skeletal abnormalities
  • Physical therapy to maximize mobility

Due to the severity of the condition, many infants with Lethal Chondrodysplasia, Moerman Type, do not survive beyond the neonatal period. Supportive care and counseling are important for families affected by this condition.

Prognosis[edit | edit source]

The prognosis for individuals with Lethal Chondrodysplasia, Moerman Type, is generally poor due to the critical nature of the skeletal and pulmonary abnormalities. The lifespan is often limited to the neonatal period or early infancy.

See Also[edit | edit source]

Lethal chondrodysplasia Moerman type Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD